153 related articles for article (PubMed ID: 36741689)
1. Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse.
Wang H; Liu L; Yan J; Ma W; Du Y; Zhang T
Front Oncol; 2022; 12():1097816. PubMed ID: 36741689
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study.
Wei ZJ; Zhou BC; Wang GX; Han WX; Li YX; Xu AM
Int J Clin Oncol; 2024 Feb; 29(2):149-158. PubMed ID: 38112831
[TBL] [Abstract][Full Text] [Related]
3. The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics.
Xu Y; Li Q; Lin Z; Lin Y
Clin Respir J; 2023 May; 17(5):374-383. PubMed ID: 36977421
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients.
Li H; Li B; Pan Y; Zhang Y; Xiang J; Zhang Y; Sun Y; Yu X; He W; Hu H
Front Oncol; 2020; 10():621435. PubMed ID: 33585249
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer.
Xie X; Wang L; Wang X; Fan WH; Qin Y; Lin X; Xie Z; Liu M; Ouyang M; Li S; Zhou C
Front Oncol; 2021; 11():672687. PubMed ID: 34055642
[TBL] [Abstract][Full Text] [Related]
6. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
[TBL] [Abstract][Full Text] [Related]
7. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules.
Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y
J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408
[TBL] [Abstract][Full Text] [Related]
8. Validation of the diagnostic efficiency of folate receptor-positive circulating tumor cells in lung cancers: a prospective observational study.
Liu J; Han M; Huang H
Transl Cancer Res; 2019 Aug; 8(4):1242-1248. PubMed ID: 35116866
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Folate Receptor-Positive Circulating Tumor Cells Are Associated With Occult Peritoneal Metastasis and Early Recurrence in Gastric Cancer Patients: A Prospective Cohort Study.
Zeng CDD; Jin CC; Gao C; Xiao AT; Tong YX; Zhang S
Front Oncol; 2022; 12():769203. PubMed ID: 35425708
[TBL] [Abstract][Full Text] [Related]
10. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules.
Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H
J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049
[TBL] [Abstract][Full Text] [Related]
11. A retrospective diagnostic test study on circulating tumor cells and artificial intelligence imaging in patients with lung adenocarcinoma.
Ma M; Xu S; Han B; He H; Ma X; Chen C
Ann Transl Med; 2022 Dec; 10(24):1339. PubMed ID: 36660706
[TBL] [Abstract][Full Text] [Related]
12. Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer.
Cheng H; Yang J; Fu X; Mao L; Chu X; Lu C; Li G; Qiu Y; He W
Front Oncol; 2022; 12():1012609. PubMed ID: 36313690
[TBL] [Abstract][Full Text] [Related]
13. Folate receptor-positive circulating tumor cells in predicting ground-glass nodules malignancy.
Yue YS; Sun ZH; Cui Q; Jiang GZ
Am J Transl Res; 2023; 15(4):2828-2835. PubMed ID: 37193191
[TBL] [Abstract][Full Text] [Related]
14. Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer.
Alessi JV; Ricciuti B; Alden SL; Bertram AA; Lin JJ; Sakhi M; Nishino M; Vaz VR; Lindsay J; Turner MM; Pfaff K; Sharma B; Felt KD; Rodig SJ; Gainor JF; Awad MM
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34824161
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.
Zhou X; Sun X; Zhao W; Fang X; Wang X
Cancer Manag Res; 2019; 11():4243-4254. PubMed ID: 31190991
[No Abstract] [Full Text] [Related]
16. The utility of folate receptor-positive circulating tumor cell in cancer diagnosis in the elderly population.
Li N; Zhong D; Chen H; Huang T; Hou P; Zhang Y; Chen F; Wang X; Zhang H
Cancer Manag Res; 2019; 11():4097-4107. PubMed ID: 31190982
[No Abstract] [Full Text] [Related]
17. Evaluation of colorectal cancer liver metastases based on liquid biopsy combined with folate receptor- Positive circulating tumor cells and HSP90.
Huang M; Cheng L; Mo S; Ru H; Mo X; Yan L
Front Oncol; 2022; 12():912016. PubMed ID: 36203415
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of blood-based biomarkers for predicting immunotherapy benefits in patients with advanced non-small cell lung cancer.
Park CK; Oh HJ; Kim MS; Koh BG; Cho HJ; Kim YC; Yang HJ; Lee JY; Chun SM; Oh IJ
Transl Lung Cancer Res; 2021 May; 10(5):2103-2117. PubMed ID: 34164263
[TBL] [Abstract][Full Text] [Related]
19. High score of LDH plus dNLR predicts poor survival in patients with HER2-positive advanced breast cancer treated with trastuzumab emtansine.
Li L; Ai L; Jia L; Zhang L; Lei B; Zhang Q
BMC Cancer; 2022 Jan; 22(1):29. PubMed ID: 34980025
[TBL] [Abstract][Full Text] [Related]
20. Folate receptor-positive circulating tumor cells as a predictive biomarker for the efficacy of first-line pemetrexed-based chemotherapy in patients with non-squamous non-small cell lung cancer.
Chen X; Zhou F; Li X; Yang G; Zhao C; Li W; Wu F; Yu J; Gao G; Li J; Li A; Ren S; Zhou C
Ann Transl Med; 2020 May; 8(10):631. PubMed ID: 32566568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]